Songwon Announces Expansion of DOTO Manufacturing Capacity

Songwon Industrial Group is announcing the expansion of DOTO (Di-n-Octyltin Oxide) production capacity by 60% at its Ulsan (Korea) manufacturing facility with the project completion expected mid 2013.

The new DOTO capacity will come at the expense of a reduction in DBTO (Di-n-Butyltin Oxide) capacity. Beyond the current project, Songwon is planning additional DOTO capacity to support future market needs.

REACH (the Registration, Evaluation, Authorisation and Restriction of Chemical substances) is the European Community Regulation on chemicals and their safe use (EC 1907/2006). Since its implementation in 2007, REACH and other global environmental regulation initiatives have become stricter. As a result the movement to replace Butyltin compounds is accelerating, especially in the European market. Songwon foresees that where possible, Butyltin compounds will be replaced by Octyltin compounds by 2015. The market demand shifting from DBTO to DOTO is the driving force behind Songwon's decision to realign manufacturing to reflect the market needs.

 

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.